Detalhe da pesquisa
1.
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
Cancer Immunol Immunother
; 60(2): 249-60, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21069321
2.
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
Clin Cancer Res
; 16(20): 5067-78, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736326